Clinical Trial Update: Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating combination chemotherapy with filgrastim or pegfilgrastim in patients with recurrent or persistent cancer of the uterus; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Corpus Leiomyosarcoma
• Uterine Corpus Sarcoma

Drugs mentioned

• Filgrastim (filgrastim)
• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma | Phase 2 | Status: COMPLETED